))
Personalizing Treatment and Managing Patient Concerns
Mark all (un)played …
Archived series ("Inactive feed" status)
When?
This feed was archived on November 23, 2020 06:25 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage series 1118507
Content provided by Projects In Knowledge, Inc and Projects In Knowledge. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Projects In Knowledge, Inc and Projects In Knowledge or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Drs. Bradley Monk and Robert Coleman examine practical issues to consider in managing toxicities associated with antiangiogenic agents: dealing with side effects of first-line versus palliative treatment, the possibility of dose reduction to alleviate toxicities, risk factors for catastrophic side effects such as RPLS and GI perforation, and whether patients with serious side effects can be re-treated when these events have resolved. They also address the role of sensitivity tests and molecular profiling in determining treatment.
…
continue reading
2 episodes
Share
